Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Sensex Trades on a Volatile Note; FMCG, Pharma Stocks Rally
Fri, 22 Jun 12:30 pm | Parth Parekh, TM Team

After opening the day flat share markets in India are trading on a dull note and are presently trading marginally above the dotted line. Sectoral indices are trading on a mixed note, with stocks in the FMCG sector and stocks in the pharma sector witnessing maximum buying interest.

The BSE Sensex is trading up by 40 points (up 0.1%) and the NSE Nifty is trading up by 12 points (down 0.1%). Meanwhile, the BSE Mid Cap index is trading up by 0.3%, while the BSE Small Cap index is trading down by 0.2%. The rupee is trading at 67.73 to the US$.

In news from stocks in the pharma sector. Glenmark Pharma share price is in focus after the US Food and Drug Administration (USFDA) approved the first product from its North Carolina, US based manufacturing facility.

The approval covers Atovaquone and Proguanil Hydrochloride tablets, a generic version of GlaxoSmithKline's Malarone tablets.

The North Carolina facility is Glenmark's first manufacturing site in the US, designed to manufacture a variety of fixed dose pharmaceutical formulations. Notably, Glenmark has invested more than USD 100 million into the facility with plans for further expansion in the coming years.

--- Advertisement ---
10 BUY Recommendations: Pay Just Rs 99 to Get Instant Access…

If you're looking for stocks you could consider buying in this fluctuating market…

Then, we have something extremely exciting for you.

Right now, you have an opportunity to join Smart Money Secrets through a Special 30-Day Trial Invitation by paying JUST Rs 99… And you will get Instant Access to 10 Guru Based Stocks we have recommended in the past which are still within their BUY limits.

But please note that this is a rare limited period offer that will expire very soon.

So, do not delay…Click here for full details…

Glenmark has 16 manufacturing facilities in Europe, India and the US.

At the time of writing, Glenmark Pharma share price was trading up by 0.5%.

Indian pharma companies catering to the US markets are breathing a sigh of relief. After being adversely affected by import bans and the suspension of new drug approvals from manufacturing facilities in the past three years, there has been a sharp pick-up in new drug approvals in FY17.

With an aim to lower the overall healthcare costs in the country, the US Food and Drug Administration (FDA) approved a record 763 generic drugs for the financial year ending 30th September. As per Mint Analysis, Indian pharma companies received 295 approvals accounting for 40% of the overall approvals during the year.

Generic Drug Approvals Hit the Roof

Even the total filings of abbreviated new drug applications (ANDAs) for generic drugs rose to 1,292 in FY17 from 852 in the previous year. While, faster approvals expedite the commercialisation of product pipelines of domestic pharma companies spurring growth. At the same time however, it has raised the intensity of competition resulting in pricing pressures. The price erosion has been further compounded by a consolidation among US distributors and the decline in the number of products going off-patent over the past few years.

In other words, acceleration in generic drug approvals is like a double-edged sword. The growth boost can be quickly offset by the ensuing pricing pressures. Pharma companies that invest in creating a pipeline of complex generics or building competencies in alternative dosage forms are better equipped to tackle the changing dynamics in the US generics market.

Therefore, despite a lot of pessimism surrounding pharma stocks on regulatory uncertainty, we have stocks in open positions in StockSelect and have remained bullish on pharma stocks in our long term service, ValuePro

Moving on to news from stocks in the banking sector. IDBI Bank share price is in focus today amid media reports stating the government was considering a proposal to sale over 40% stake in the company to the Life Insurance Corporation of India (LIC).

A stake sale of 40-43% in the lender could net the government over Rs 100-110 billion.

The government owns over 81% stake in IDBI Bank, while LIC holds 10.8%.

However, neither of the parties have confirmed such a stake sale, and the iInvestment decision will go through LIC Investment & Strategy Committee and the quantum of stake buy will depend on negotiations & decision by the committee.

Notably, the government had announced that it would bring its stake in IDBI Bank below 50% in the Union Budget 2016.

The IDBI Bank board is scheduled to meet soon to draw capital raising plan for the next five years.

At the time of writing, IDBI Bank share price was trading up by 2%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Sensex Trades on a Volatile Note; FMCG, Pharma Stocks Rally". Click here!


Stock Market Updates

BAJAJ AUTO plunges by 5%; BSE AUTO Index Down 1.2% (Today's Market)

Jul 23, 2018 12:36 PM

BAJAJ AUTO share price has plunged by 5% and its Current Market Price is Rs 2,854. The BSE AUTO is down by 1.22%. The top gainers in the BSE AUTO Index are ASHOK LEYLAND (up 1.35%) and CUMMINS INDIA (up 0.56%). The top losers are BAJAJ AUTO (down 5.34%) and HERO MOTOCORP (down 8.04%).

The BSE FMCG Index has hit an all-time high at 11,609 (up 2.0%) (Today's Market)

Jul 23, 2018 10:30 AM

The BSE FMCG Index has hit an all-time high at 11,609 (up 2.0%). Among the top gainers in the BSE FMCG Index today are VST INDUSTRIES and GODFREY PHILLIPS. Meanwhile, the BSE Sensex has surged 0.13% to 36,631.

Sensex Opens Marginally Higher; Asian Paints & ITC Top gainers (Today's Market)

Jul 23, 2018 09:30 am

Indian share markets open marginally higher with Sensex trading up by 74 points, while the Nifty is trading up by 28 points.

WIPRO plunges by 5%; BSE IT Index Up 0.1% (Today's Market)

Jul 23, 2018 09:29 AM

WIPRO share price has plunged by 5% and its Current Market Price is Rs 288. The BSE IT is up by 0.14%. The top gainers in the BSE IT Index are NIIT LTD (up 1.27%) and HCL TECH. (up 1.24%). The top losers are WIPRO (down 5.32%) and 8K MILES SOFT (down 10.00%).

JUBILANT FOODWORKS plunges by 6%; BSE 500 Index Up 0.4% (Today's Market)

Jul 23, 2018 09:29 AM

JUBILANT FOODWORKS share price has plunged by 6% and its Current Market Price is Rs 1,490. The BSE 500 is up by 0.40%. The top gainers in the BSE 500 Index are PC JEWELLER (up 10.74%) and UPL LIMITED (up 7.70%). The top losers are JUBILANT FOODWORKS (down 6.10%) and WIPRO (down 5.32%).

PC JEWELLER surges by 12%; BSE 500 Index Up 0.4% (Today's Market)

Jul 23, 2018 09:25 AM

PC JEWELLER share price has surged by 12% and its Current Market Price is Rs 94. The BSE 500 is up by 0.37%. The top gainers in the BSE 500 Index is PC JEWELLER (up 12.33%). The top losers are VA TECH WABAG (down 0.01%) and GLENMARK PHARMA (down 0.03%).

View More Indian Share Market News

Most Popular

Sintex's Auditor Resigns. How You Can Protect Yourself from Such Stocks(The 5 Minute Wrapup)

Jul 20, 2018

While the attack on the bad corporate governance is an overhang in the near term...this can be a game-changer in the years to come.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

PPF v/s Mutual Funds: Which Is Better?(Outside View)

Jul 10, 2018

PersonalFN highlights the key points of distinction between PPF and mutual funds.

ICICI Pru Mutual Fund Tarakki Karega! - The Unethical Way?(Outside View)

Jul 11, 2018

PersonalFN explains how ICICI Prudential Mutual Fund flouted the norms of related party transactions while subscribing to the IPO of ICICI Securities.


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Jul 23, 2018 03:21 PM